Araris Biotech raised €24M in a funding round in Oct 2022. The company is based in Zurich, Switzerland. Investors in the round: 4BIO Capital, btov Partners, Institute for Follicular Lymphoma Innovation and 5 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
